Skip to content

NOVO HOLDINGS A/S

Follow

13F filer, CIK 1388325, HELLERUP, Denmark

NOVO HOLDINGS A/S reported $1,489,688,141 across 27 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 73.66% of the portfolio.

Accepted , ingested 13F-HR 0001388325-26-000051

Period
2026-09-30
Reported value
$1.49B
Holdings
27
Top 10 weight
73.66%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OBXnew+3,123,992$42.9M
BNadded+968,790$35.3M
SRRKnew+460,002$22.2M
INSMadded+163,702$18.7M
CTNMnew+704,013$9.45M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CRNXexited-1,320,000-$49.4M
MPLTreduced-1,600,000-$16.3M
AVLNreduced-434,098-$12.4M
PHVSreduced-380,574-$12.1M
AVBPreduced-325,000-$9.84M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001388325-26-000051, largest first. % of portfolio is the value over $1,489,688,141, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,000,000 shares; 2025Q1: 5,350,000 shares; 2025Q2: 5,350,000 shares; 2025Q3: 5,350,000 shares; 2025Q4: 5,350,000 shares; 2026Q1: 5,350,000 shares; 2026Q2: 5,350,000 shares; 2026Q3: 5,350,000 shares 5,350,000$217M14.58%0Timeline
ASMLASML HLDG NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 165,836 shares; 2025Q1: 165,836 shares; 2025Q2: 165,836 shares; 2025Q3: 145,836 shares; 2025Q4: 113,946 shares; 2026Q1: 94,946 shares; 2026Q2: 94,946 shares; 2026Q3: 94,946 shares 94,946$172M11.55%0Timeline
BNBROOKFIELD CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,798,830 shares; 2025Q1: 2,330,830 shares; 2025Q2: 2,330,830 shares; 2025Q3: 2,330,830 shares; 2025Q4: 3,496,245 shares; 2026Q1: 3,496,245 shares; 2026Q2: 3,496,245 shares; 2026Q3: 4,465,035 shares 4,465,035$163M10.93%+968,790Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,180,550 shares; 2026Q3: 4,180,550 shares 4,180,550$129M8.65%0Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,883,289 shares; 2026Q3: 3,449,191 shares 3,449,191$98.3M6.6%-434,098Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,500,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,055 shares; 2025Q3: 1,264,028 shares; 2025Q4: 1,264,028 shares; 2026Q1: 1,325,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 1,125,000 shares 1,125,000$96.2M6.46%0Timeline
CRMSALESFORCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 293,901 shares; 2025Q1: 272,801 shares; 2025Q2: 330,187 shares; 2025Q3: 330,187 shares; 2025Q4: 330,187 shares; 2026Q1: 393,187 shares; 2026Q2: 393,187 shares; 2026Q3: 393,187 shares 393,187$90.3M6.06%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,084,432 shares; 2025Q3: 1,426,260 shares; 2025Q4: 1,480,000 shares; 2026Q1: 1,280,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$45.8M3.08%0Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,500,000 shares; 2025Q1: 1,950,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 3,650,737 shares; 2026Q1: 3,650,737 shares; 2026Q2: 3,249,178 shares; 2026Q3: 3,000,000 shares 3,000,000$42.9M2.88%-249,178Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,123,992 shares 3,123,992$42.9M2.88%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 915,000 shares; 2025Q2: 916,160 shares; 2025Q3: 916,160 shares; 2025Q4: 916,160 shares; 2026Q1: 860,000 shares; 2026Q2: 800,000 shares; 2026Q3: 710,000 shares 710,000$40.4M2.71%-90,000Timeline
FNDFLOOR & DECOR HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 797,000 shares; 2026Q3: 797,000 shares 797,000$36.5M2.45%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,250,000 shares; 2025Q1: 2,250,300 shares; 2025Q2: 2,380,000 shares; 2025Q3: 2,380,000 shares; 2025Q4: 2,380,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 2,135,000 shares; 2026Q3: 1,750,000 shares 1,750,000$36M2.42%-385,000Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,520,627 shares; 2025Q1: 1,872,142 shares; 2025Q2: 1,872,142 shares; 2025Q3: 1,942,142 shares; 2025Q4: 1,942,142 shares; 2026Q1: 1,942,142 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,175,000 shares 1,175,000$35.6M2.39%-325,000Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 724,666 shares; 2025Q1: 724,666 shares; 2025Q2: 680,000 shares; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: not reported; 2026Q2: 120,723 shares; 2026Q3: 284,425 shares 284,425$32.5M2.18%+163,702Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,725,000 shares; 2025Q1: 1,725,000 shares; 2025Q2: 1,725,000 shares; 2025Q3: 1,750,000 shares; 2025Q4: 1,750,000 shares; 2026Q1: 1,750,000 shares; 2026Q2: 1,400,000 shares; 2026Q3: 1,019,426 shares 1,019,426$32.3M2.17%-380,574Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,200,000 shares; 2025Q2: 1,200,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,200,000 shares; 2026Q2: 1,025,000 shares; 2026Q3: 950,000 shares 950,000$30.8M2.07%-75,000Timeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 452,327 shares; 2025Q1: 372,327 shares; 2025Q2: 372,327 shares; 2025Q3: 257,327 shares; 2025Q4: 257,327 shares; 2026Q1: 257,327 shares; 2026Q2: 257,327 shares; 2026Q3: 257,327 shares 257,327$27.7M1.86%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 485,438 shares; 2026Q2: 485,438 shares; 2026Q3: 652,105 shares 652,105$24.3M1.63%+166,667Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 460,002 shares 460,002$22.2M1.49%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 960,394 shares; 2026Q3: 1,376,164 shares 1,376,164$22.2M1.49%+415,770Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,686,622 shares; 2026Q1: 3,686,622 shares; 2026Q2: 3,686,622 shares; 2026Q3: 2,086,622 shares 2,086,622$21.3M1.43%-1,600,000Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 704,013 shares 704,013$9.45M0.63%newTimeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,100,000 shares; 2026Q3: 1,250,000 shares 1,250,000$9.24M0.62%+150,000Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,961,317 shares; 2025Q4: 1,961,317 shares; 2026Q1: 2,185,923 shares; 2026Q2: 2,250,000 shares; 2026Q3: 2,250,000 shares 2,250,000$9.22M0.62%0Timeline
MQMARQETA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 441,558 shares; 2025Q1: 441,558 shares; 2025Q2: 441,558 shares; 2025Q3: 441,558 shares; 2025Q4: 441,558 shares; 2026Q1: 441,558 shares; 2026Q2: 441,558 shares; 2026Q3: 110,389 shares 110,389$1.88M0.13%-331,169Timeline
LNZALANZATECH GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 158,148 shares; 2025Q4: 158,148 shares; 2026Q1: 158,148 shares; 2026Q2: 158,148 shares; 2026Q3: 158,148 shares 158,148$903K0.06%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CRNXCRINETICS PHARMACEUTICALS IN1,320,000$49.4Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001388325-26-000051 base2026-11-16